Since Pfizer was founded by cousins Charles Pfizer and Charles Erhart in 1849, our pharmaceutical company has remained dedicated to discovering and developing new, and better, ways to prevent and treat disease and improve health and wellbeing for people around the world. Headquartered in New York, today we are one of the world’s largest biopharmaceutical companies, with a broad and diversified global product portfolio, and leadership in virtually all key high-growth therapeutic areas.
Good health is vital to all of us and finding sustainable solutions to the most pressing global health care challenges of our world cannot wait. That's why we at Pfizer are committed to applying science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe, effective, and affordable medicines and related health care services to the people who need them.
After more than 170 years of treating and preventing disease, we’ve arrived at a new era; time of extraordinary focus on our science and the value it brings to people around the world. We strive to set the standard for quality, safety and value in the discovery, development, and manufacturing of healthcare products.
At Pfizer Egypt, for over 60 years, we have been working tirelessly, in partnership with healthcare professionals, communities, and governments, to change the lives of millions of patients. We partner to increase access and affordability of Pfizer's breakthroughs in core therapeutic areas, including vaccines, medicines for oncology, inflammation and immunology, internal medicine, rare diseases, and anti-infectives and sterile injectables used both in and outside of the hospital setting. With our 338 employees, we continue to be driven by science. Breakthroughs that change patients' lives are at the center of our operations, and our goal is to maximize patient impact by delivering these breakthroughs to all patients, regardless of where they live, which fuels everything we do.
Breakthroughs that change patients’ lives
Pfizer’s purpose is to deliver breakthroughs that change patients’ lives. R&D is at the heart of fulfilling Pfizer’s purpose as we work to translate advanced science and technologies into therapies that matter most.
We have a leading portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and we have an industry-leading pipeline of promising new products that have the potential to challenge some of the most feared diseases of our time, like Alzheimer’s disease and cancer.
To fully realize Pfizer’s purpose - Breakthroughs that change patients’ lives - we have established a clear set of expectations regarding “what” we need to achieve for patients and “how” we will go about achieving those goals.
The “how” is represented by four simple, powerful values - courage, excellence, equity, and joy – that define our company and our culture.
Courage. Breakthroughs start by challenging convention, especially in the face of uncertainty or adversity. This happens when we think big, speak up and are decisive.
Excellence. We only change patients’ lives when we perform at our best together. This happens when we focus on what matters, agree who does what and measure our outcomes.
Equity. We believe that every person deserves to be seen, heard, and cared for. This happens when we are inclusive, act with integrity and reduce health care disparities.
Joy. We give ourselves to work, but it also gives to us. We find joy when we take pride, recognize one another, and have fun.
Our company goal is very clear, which is to create breakthroughs that change patients' lives (“Breakthroughs that change patients' lives ®”) .
Despite operating in a complex environment, our company continues to leverage the full power of our assets – from medicines, vaccines, to our financial investments and expertise – to help strengthen healthcare systems and increase access to quality healthcare for patients across the globe. world.
Together with our partners, Pfizer strives to provide transformative and sustainable solutions through our programs and investments to create a healthier world for every individual.
We believe that all patients deserve to have access to the best possible therapy they need.
We support multi-lateral healthcare institutions and adopt an innovative product pricing approach that combines philanthropic and business approaches to increase access to medicines and vaccines in areas where they are most needed.
We support initiatives that comprehensively strengthen public health systems and assist joint efforts to achieve the United Nations Sustainable Development Goals.
Our contribution to communities in need starts from training health workers on the front lines and participating in providing supporting infrastructure, increasing care support, to providing grants and investments for public health in various countries around the world.
Embodied within the Pfizer logo is the core of the company, its history, and its future.
Pfizer has evolved beyond being just a pharmaceutical company. Our dynamic new logo is the result of scientific innovation. We've changed the pill-shaped logo to reveal the essence of what we're doing right now: a double helix, moving upwards.
This logo consists of two forms that are attached to each other. The union symbolizes our passion and dedication to science, which is the foundation behind our innovation, and to the health of the patients we serve.
Pfizer introduces a new corporate logo design that symbolizes Pfizer's goal, which is to create “Breakthroughs that change patients' lives®”)
“After 171 years, we have arrived in a new era - an era marked by a focus on science and dedication to patients. Pfizer is no longer focused solely on treating disease - we treat and prevent disease.”
-- Albert Bourla, Chairman and Chief Executive Officer
“This new identity reflects Pfizer’s long history, with a passion for innovation and a focus on science.”
-- Sally Susman, Executive Vice President, Chief Corporate Affairs Officer